Other Events ·
ABVC BioPharma postponed the previously announced distribution of ordinary shares in its subsidiary, BioKey (Cayman)…
ABVCAbvc Biopharma, Inc.
ABVC BioPharma postponed the previously announced distribution of ordinary shares in its subsidiary, BioKey (Cayman), Inc., from August 3 to August 21, 2026. The company cited the need for additional time to complete administrative, regulatory, and tax-related matters. The record date remains July 24, 2026, and the distribution ratio is unchanged at 0.169464 BioKey shares per ABVC share. The prior ex-dividend date will be revised once finalized. This biotechnology company develops therapies for rare diseases.